Loading...
XNAS
MASI
Market cap7.65bUSD
Dec 05, Last price  
141.68USD
1D
-0.41%
1Q
-3.74%
Jan 2017
110.21%
IPO
591.12%
Name

Masimo Corp

Chart & Performance

D1W1MN
XNAS:MASI chart
P/E
P/S
3.65
EPS
Div Yield, %
Shrs. gr., 5y
-1.37%
Rev. gr., 5y
17.43%
Revenues
2.09b
+2.26%
107,890,000224,338,000256,286,000307,074,000349,115,000405,407,000438,988,000493,233,000547,245,000586,643,000630,111,000694,625,000798,108,000858,289,000937,837,0001,143,744,0001,239,153,0002,035,800,0002,048,100,0002,094,400,000
Net income
-305m
L
33,381,000181,826,00042,255,00031,927,00053,228,00073,530,00063,700,00062,272,00058,381,00072,518,00083,300,000300,666,000131,616,000193,543,000196,216,000240,300,000229,600,000143,500,00081,500,000-304,900,000
CFO
196m
+108.71%
4,541,000189,631,00028,823,00078,178,00047,121,00061,020,00078,957,00075,434,00054,317,00095,459,000114,209,000416,842,00058,108,000239,527,000221,640,000210,963,000264,754,00029,500,00094,100,000196,400,000
Dividend
Nov 23, 20121 USD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Masimo Corporation develops, manufactures, and markets noninvasive monitoring technologies and hospital automation solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry. It also provides Masimo rainbow SET platform that includes rainbow SET Pulse CO-Oximetry products that noninvasively monitor hemoglobin species, including oxygen saturation, pulse rate, perfusion index, pleth variability index, and respiration rate from the pleth; noninvasively monitor hemoglobin concentration, and carboxyhemoglobin and methemoglobin; monitor arterial oxygen saturation and acoustic respiration rate; and calculates oxygen content and oxygen reserve index. It offers SedLine brain function monitoring technology to measure the brain's electrical activity by detecting EEG signals; capnography and gas monitoring products comprising external plug-in-and-measure capnography and gas analyzers, integrated modules, handheld capnograph and capnometer devices, and capnography sampling lines; O3 regional oximetry for tissue oxygen saturation measurement; and hemodynamic monitoring solutions. Its Masimo Hospital Automation platform includes Patient SafetyNet, Patient SafetyNet surveillance, Kite, UniView, Replica, UniView : 60, and MyView. It offers connectivity devices; and nasal high flow ventilation and neuromodulation solutions. It provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, long-term care facilities, physician offices, veterinarians, and consumers; and non-medical/consumer products through e-commerce site, masimopersonalhealth.com. The company was incorporated in 1989 and is headquartered in Irvine, California.
IPO date
Aug 08, 2007
Employees
4,000
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122022‑002021‑002019‑122018‑122017‑122016‑122016‑00
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT